Type 2 diabetes remission in 54% with diet and exercise
In the RESET for Remission trial of 96 adults, early type 2 diabetes went into remission after 24 weeks in 27 of 50 on the program, versus 2 of 46 in the control group.

Type 2 diabetes remission was reached by 27 of 50 adults who spent six months on a diet of 800 to 900 kcal a day and exercised regularly, according to the RESET for Remission trial. Researchers from McGill University in Montreal and the University of Leicester presented the results at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, which runs until October 2, 2026. The work was published in The Lancet Regional Health Americas.
The trial is led by Professor Kaberi Dasgupta of McGill and Professor Thomas Yates of Leicester. It deals with early type 2 diabetes, meaning the kind that develops before age 45. The authors describe it as a distinct clinical form, with faster deterioration of blood sugar control, earlier complications and a shorter life expectancy than disease that starts later.
How was the trial run?
At three centers, in Leicester, Montreal and Edmonton, 96 adults aged 18 to 45 were randomly assigned between September 24, 2021 and June 6, 2025. All had early type 2 diabetes and obesity, and none was taking insulin. Forty came from the United Kingdom and 56 from Canada, with an average age of 38 and a body mass index of 35.2. The intervention group had 24 women and 26 men, the control group 21 women and 25 men. The control group received usual care.
Participants in the program stopped their diabetes and blood pressure medication (except where albuminuria was present) and moved to a diet of 800 to 900 kcal a day, made up of 30% protein, 50% carbohydrate and 20% fat. The program ran in three steps:
- weeks 1 and 2: meal replacements only (Optifast),
- weeks 3 to 12: the same energy intake, using meal replacements (Optifast in the United Kingdom, ProtiDiet in Canada) plus one real meal a day with 60 to 90 grams of protein, one portion of fruit and two portions of vegetables,
- weeks 13 to 24: a weight maintenance diet.
Through week 12 the program also included exercise: supervised aerobic and strength training twice a week, plus one unsupervised session. Medscape, in a report that cites three supervised sessions a week, differs on this detail from the description published by Medical Xpress and News Medical. This article keeps the description from the study announcement.
What did the numbers show?
Remission was defined as a glycated hemoglobin (HbA1c) value below 6.5% (48 mmol/mol) with no glucose-lowering medication for at least 12 weeks. After 24 weeks, this was achieved by 27 of 50 participants in the program (54%) and 2 of 46 in the control group (4%). After statistical adjustment, the odds of remission were 21 times higher in the program group.
Average weight in the intervention group fell from 100.7 to 92.3 kilograms, a loss of 8.4 kg. The control group went from 103.2 to 102.0 kilograms, a loss of 1.2 kg. The adjusted difference is 7.5 kg, of which 6.6 kg is additional fat loss, while muscle mass was preserved.
Most program participants, 43 of 50, had at least one side effect, compared with 6 of 46 in the control group. These were mostly effects of the diet early on, such as constipation, headache, dizziness and fatigue, and they passed. There were no serious adverse events.
In a statement, the authors of the study say:
“Our findings demonstrate the feasibility and efficacy of combining structured aerobic and resistance exercise with a low-energy diet in early-onset type 2 diabetes, supporting its potential to deliver substantial and comprehensive health and well-being benefits alongside diabetes remission.”
The same authors judge that the remission rates in this trial sit at the top of those reported earlier:
“Our remission rates are at the upper end of those previously reported in the literature for trials of similar duration.”
What does this not prove?
The trial lasted 24 weeks, so it says nothing about how long remission lasts. The authors themselves note that most people partly or fully regain weight after any weight loss program, and that regained weight may restore more fat tissue than muscle. They are therefore cautious about muscle preservation:
“Our RESET for Remission trial targeted muscle during the intensive weight loss phase through resistance training, and our findings show that preservation of lean and muscle mass is possible with rapid weight loss. Preserving muscle during remission-focused weight loss may have important implications for long-term metabolic health, physical function and disease trajectory. This needs to be tested in a longer trial.”
The trial was open label, meaning participants and researchers knew who was in which group, while the outcome was assessed blind. In the main analysis, everyone who was randomized was counted as not in remission when data were missing, and 86 of 96 participants (90%) completed the final assessments. The trial does not compare diet and exercise against each other, because it tests their combination against usual care, so it cannot say how much each component contributes to the result.



